Science & Research

A study published this month found no significant links to increased psychosis-related conditions in states that have passed medical and/or adult-use cannabis legalization policies.

A recent study found there is little evidence supporting the notion that cannabis “hangovers” can stymie next-day performance.

Researchers at Australia’s University of Sydney have launched the world’s first-ever study investigating the efficacy of CBD treatments for spinal cord injury-induced chronic pain.

A new report found cannabis legalization does not lead to an increase in substance use disorders or the increased use of illicit drugs.

The FDA released its proposed final guidance for research related to developing drugs containing cannabis or cannabis-derived compounds.

Three out of 10 adults with chronic pain in states with legal medical cannabis access use cannabis products to manage their pain, according to a recent study.

The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) released guidelines calling for all patients to be screened for cannabis use before surgery, citing concerns that regular cannabis consumers can experience more post-op pain and nausea.

Cannabis researchers published more than 4,300 studies investigating the effects and therapeutic benefits of cannabis this year, more than any other year.

According to statistics from car insurance companies, cannabis law reforms have made no statistically significant impact on the rate of vehicular accidents in Canada and the U.S.

In the second installment of our 2023 predictions series, we asked experts in cannabis science, cultivation, and agricultural technology — as well as industrial hemp and psychedelics — to weigh in with their industry expectations for the next year.

President Joe Biden signed the nation’s first standalone cannabis reforms bill last week, paving the way for researchers to more easily investigate the plant’s medicinal properties.

The Senate passed a House-approved medical cannabis research bill yesterday, making it the first standalone cannabis reforms bill ever delivered to the president’s desk.

A Florida company has announced clinical trials for the first-ever drug seeking to treat cannabis use disorder.

A recent report found the international medical cannabis market could grow an estimated 19% from 2022 to 2028 to reach a $40 billion global value.

The California Department of Cannabis Control has earmarked $20 million in funding for research prioritizing multiple cannabis topics including potency, health impacts, medicinal use, legacy cannabis genetics, and the health of California’s cannabis industry.

Adult-use cannabis sales launched in Vermont over the weekend; at least 70 Vermont municipalities have opted to allow retail cannabis sales.

Rutgers University researchers found a 2% increase in home prices where municipalities have allowed licensed cannabis businesses to operate compared to areas that instituted bans on the industry.

A recent study by UK researchers found that cannabis consumption is not associated with increased apathy among adults and adolescents.

Active cannabis consumers fared better against COVID-19 than non-consumers according to preliminary research published this month in the Journal of Cannabis Research.

Michigan is giving $12.5 million to two universities to facilitate research into the potential therapeutic benefits of cannabis for veterans suffering from PTSD.

Filament Health has begun its Phase 1 study investigating naturally-derived psilocin and psilocybin, the first such study ever approved by the FDA.

A recent UN report noted an uptick in cannabis consumption tied to the COVID-19 pandemic as well as legalization policies around the world.

A special report by Project CBD details the chemistry of cannabinoids and how a concept called chirality enables the synthetic production of new cannabinoids like Delta-8 THC; the report also highlights the risk of potentially unleashing new, “hidden dangers” in the process.

A recent New Frontier Data report found that 39% of millennials who are cannabis consumers typically use cannabis multiple times per day.